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 23 
The aims of the study were to determine the long-term effects of dietary supplementation with 24 
microalgae (SCIM) on milk and blood fatty acid (FA) composition and reproductive hormones in 25 
early lactation dairy cows. Sixty Holstein-Friesian dairy cows (30 per treatment) were 26 
unsupplemented (Control) or supplemented with 100 g of SCIM (Schizochytrium imancinum sp) 27 
per cow per day from 25 ± 0.5 days post-partum for 98 days. Intake and milk yield were recorded 28 
daily, with milk samples collected at weeks 0, 1, 2, 4, 8 and 14, and blood samples collected 29 
from 12 representative pairs per treatment at weeks 0, 2, 4, 8, and 14 for subsequent analysis 30 
of FA, β-hydroxybutryate, non-esterified fatty acids and glucose. At 33 ± 0.9 days postpartum 31 
the oestrus cycle of 24 cows (12 per treatment) were synchronised and plasma 13,14-dihydro-32 
15-keto PGF2α (PGFM) concentrations determined following an oxytocin challenge. Data were 33 
analysed by repeated measures analysis of variance. There was no effect of treatment on dry 34 
matter intake, milk yield or milk fat content, with mean values across treatments of 22.1 and 35 
40.6 kg/d, and 37.2 g/kg respectively. Milk fat concentration of C22:6 n-3 increased rapidly in 36 
cows receiving SCIM, reaching a maximum of 0.38 g/100 g FA by week 14. Similarly, blood 37 
concentration of C22:6 n-3 increased to 1.6 g/100 g FA by week 14 in cows fed SCIM. There 38 
was no effect of treatment on plasma metabolites, but plasma glucose was lower in cows fed 39 
SCIM compared to the Control at week 2, and higher in weeks 4 and 8. There was no effect of 40 
treatment on peak plasma PGFM concentration or area under the curve. It is concluded that 41 
feeding SCIM rapidly increases blood and milk concentrations of C22:6 n-3 which are 42 
maintained over time, but does not improve plasma PGFM in dairy cows. 43 
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Increasing the content of very long chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) such 50 
as eicosapentaenoic acid (C20:5n-3) and docosahexaenoic acid (C22:6n-3) in food products is 51 
of interest due to their role in the prevention of certain cancers, development of the retina and 52 
brain tissue, anti-inflammatory properties, and their role in the modulation and prevention of 53 
coronary heart disease (Zarate et al. 2017). Several studies have successfully increased the LC 54 
n-3 PUFA content of dairy and meat products by supplementing with marine sources such as 55 
fish oil (FO) or microalgae (Rodriguez-Herrera et al. 2017; Vanbegue et al. 2018). The transfer 56 
efficiency of LC n-3 PUFA from marine sources to milk is, however, low (Chilliard et al. 2001) 57 
as the majority of the PUFA are biohydrogenated in the rumen to saturated fatty acids (FA) or 58 
their intermediaries (Sinclair et al. 2005). Additionally, a time dependent adaptation of the rumen 59 
to supplementation with LC n-3 PUFA and production of intermediaries has also been reported 60 
in some studies, further reducing the flow of PUFA to the small intestine (Shingfield et al. 2006). 61 
Most studies that have examined the effect of feeding LC n-3 PUFA have however, been short-62 
term, and there is a lack of information on the long-term effects of supplementation on blood 63 
and milk FA profiles.  64 
The fertility of dairy cows in most Western countries has declined over the past five 65 
decades, which has been associated with an intensification of production and higher milk yields 66 
(Rodney et al. 2015). Polyunsaturated FA have a major role in the endocrine system, 67 
metabolism and disease control, influencing the reproductive status of dairy cows in various 68 
ways. For example, the series 1 and 2 prostaglandins are synthesised from n-6 PUFA and are 69 
intimately involved in uterine involution and subsequent ovulation post-partum (Otto et al. 2014).  70 
In contrast, the 3 series prostaglandins are synthesised from n-3 PUFA and are involved in 71 
improving the environment for embryo implantation and survival by decreasing the secretion of 72 
PGF2α, resulting in an increased lifespan of the corpus luteum (CL) (Dong Hyeon et al. 2016), 73 
improvement in blastocyst cell numbers, and maintenance of pregnancy (Otto et al. 2016). The 74 
objective of this study was to determine the effect of supplementation with microalgae that is 75 
high in C22:6 n-3 on milk and blood LC n-3 PUFA concentrations over a 14 week period, and 76 
to determine the effect on the synthesis of PGF2α. 77 
 78 
Material and methods 79 
The study was conducted in accordance with the requirement of the Animals (Scientific 80 
Procedures) Act 1986 (amended 2013) and received local ethical approval (reference 0115).  81 
 82 
 Animals, diets and experimental design 83 
Sixty Holstein-Friesian dairy cows (12 primiparous and 48 multiparous) were randomly allocated 84 
into  two homogenous groups  at 25 ± 0.5 days post calving based on parity and milk yield in 85 
the 7 days prior to the start of the study. Animals remained on treatment for 14 weeks and each 86 
group received one total mixed ration (TMR) that was either unsupplemented (Control) or 87 
supplemented with 100 g/day of dried Schizochytrium imancinum sp., (SCIM; Alltech, Kentucky, 88 
USA; Table 1). Cows in the Control group received an additional 100 g per cow per day of a 89 
rolled wheat/sugar beet feed mixture to provide a similar energy intake. Cows were fed the TMR 90 
once daily at 0900 h at 1.05 of the previous days intake via roughage intake feeders (Insentec 91 
B.V., Marknesse, The Netherlands) fitted with an automatic animal identification and weighing 92 
system calibrated to ±0.1 kg. Feed intake was recorded daily and the diets sampled weekly and 93 
stored at -20 °C for subsequent analysis. The SCIM contained 135 g/kg DM crude protein, 580 94 
g/kg oil and (g/100 g FA)  3.7, 1.5, 53.9, 1.7, 0.28, and 25.7 as C14:0, C14:1 cis-9, C16:0, C18:0, 95 
C20:5 n-3, and C22:6 n-3, respectively. From calving to the start of the study the cows were fed 96 
the same basal ration that did not contain SCIM. All cows had free access to salt blocks and 97 
water throughout the study.  98 
  All cows were milked twice daily at 0615 and 1600 h. Milk yield was recorded daily and 99 
cows were weighed and body condition scored (BCS; Ferguson et al. 1994) at approximately 100 
1100 h at 1 week prior to the start of study, then every other week. Milk samples were collected 101 
weekly at consecutive am and pm milkings for subsequent analysis. During weeks 0, 1, 2, 4, 8 102 
and 14 of the study milk samples were collected at 2 consecutive am and pm milkings from 16 103 
representative pairs of cows per group (based on their parity and milk yield in the week prior to 104 
allocation) and pooled based on the respective am and pm milk yield for FA determination.  105 
 106 
Blood metabolites and reproductive hormones 107 
Blood samples were collected from the jugular vein from 12 representative pairs of cows (based 108 
on their parity and milk yield in the week prior to allocation) at 1100 h during weeks 0, 2, 4, 8 109 
and 14. Samples were centrifuged at 1000 g for 15 min, the plasma separated and stored at -110 
20°C prior to subsequent analysis. At day 33 (± 0.9) postpartum, 24 representative cows (12 111 
per treatment group cows based on their parity and milk yield in the week prior to allocation) 112 
were synchronized in pairs using progesterone releasing intra-vaginal devices (PRID; Ceva 113 
Prid®Delta, Ceva Animal Health Ltd., Amersham, UK). The PRID’s were removed after 10 d, 114 
and on day 17 of the synchronised oestrous cycle (Robinson et al., 2002), a catheter was 115 
inserted into the jugular vein following sedation with Sedaxylan (20 mg/ml xylazine solution at 116 
0.5 ml/100 kg; Dechra Pharmaceuticals PLC, Northwich, UK) injected into the coccygeal vein. 117 
Blood samples were collected via the jugular catheter at 15 min intervals for 1 h prior to the 118 
administration of oxytocin (100 IU; MSD Animal Health, Milton Keynes, UK), and at 15 min 119 
intervals for a further 3 h, and then at 30 min intervals until 4 h post oxytocin infusion to monitor 120 
uterine secretion of 13,14-dihydro-15-keto PGF2α metabolite (PGFM). The blood was 121 
centrifuged at 1000 g for 15 min and the plasma frozen at -20°C prior to subsequent analysis.  122 
 123 
Chemical analysis 124 
The TMR samples were bulked within each month and a sub-sample analysed according to 125 
AOAC (2012) for DM (934.01), CP (988.05) and ash (924.05), whilst NDF was analysed 126 
according to Van Soest et al. (1991). Feed, milk and plasma fatty acid extraction and analysis 127 
are provided in the Supplementary Material. Milk fat, protein and somatic cell count (SCC) was 128 
determined at the National Milk Laboratories (Four Ashes, UK). Plasma samples were analysed 129 
for, 3-OHB, glucose and non-esterified fatty acids (NEFA) (kit catalogue no; RB1008; GU611 130 
and FA115, respectively Randox Laboratories, County Antrium, UK), using a Cobas Mira Plus 131 
autoanalyser (ABX Diagnostics, Bedfordshire, UK). Plasma concentration of PGFM, was 132 
assayed using an ELISA kit (Cayman Chemical, Ann Arbour, MI, USA) with an inter- and intra-133 
assay coefficient of variation of 13.0 and 9.9 % respectively.  134 
 135 
Calculations and statistical analysis 136 
All data were checked for normal distribution and analysed using Genstat 17th edition (VSN. 137 
Ltd, Oxford, UK). The SCC data were converted to their natural log prior to analysis. Daily live 138 
weight and body condition change were calculated as the final minus the initial value divided 139 
by the days on study. The PGFM area under the curve was calculated as described by 140 
Robinson et al. (2002). Variables having more than one observation were analysed using 141 
repeated measures ANOVA as: Yijk = μ + Pi + Dj + Tk + D.Tjk + εijk, where Yijk = dependent 142 
variable; μ = overall mean; Pi = fixed effect of pair; Dj = effect of diet, Tk = effect of time; D.Ajk 143 
= interaction between diet and time and εijk = residual error. Variables with one observation 144 
were analysed by ANOVA using Genstat 18th edition (VSN Ltd., Oxford, UK).  145 
Results 146 
Feed analysis  147 
The treatment diets had a similar chemical position with a mean DM of 378 g/kg, OM of 927 148 
g/kg DM, CP of 162 g/kg DM and NDF of 419 g/kg DM, whereas the pre-study diet was higher 149 
in CP and lower in NDF (Table 1). The pre-study diet had also a higher concentration of C14:0 150 
and C16:0 compared to the treatment diets. The SCIM diet contained 0.01 g/kg DM of C20:5 n-151 
3 and 0.71 g/kg DM C22:6 n-3, whereas the pre-study and Control diets did not contain any 152 
detectable levels.  153 
 154 
Animal performance and blood metabolites 155 
There was no effect (P > 0.05) of dietary treatment on DM intake, with a mean value of 156 
22.1 kg/d (Table 2), but was affected by time (P < 0.001), increasing from 21.1 kg/d in week 1 157 
of the study to 23.4 kg/d at week 3 before decreasing to 20.9 kg/d at week 14. Similarly, there 158 
was no effect (P > 0.05) of treatment on daily milk yield with a mean value of 40.6 kg/d, and a 159 
peak yield of 42.2 kg/d occurring during week 3 of the study. Mean milk fat content was 37.2 160 
g/kg and fat yield 1.49 kg/d, and were not affected by dietary treatment (P > 0.05), with both 161 
decreasing over time (P = 0.048 and 0.013 respectively). Milk protein content and yield were 162 
not affected (P > 0.05) by dietary treatment, and decreased with time (P < 0.001). There was 163 
no effect (P > 0.05) of dietary treatment on live weight, which increased by 0.23 kg/d over the 164 
14 week (P < 0.001). Body condition score was unaffected (P > 0.05) by treatment or time. 165 
There was no effect (P > 0.05) of dietary treatment on the mean concentration of plasma 166 
3-OHB, glucose or NEFA (Table 2). Plasma NEFA tended to decrease (P = 0.06) from week 2 167 
to week 14 of the study, whilst plasma glucose was lower in cows receiving SCIM compared to 168 
the Control at week 2, and higher in weeks 4 and 8 (P < 0.05). 169 
 170 
Milk and plasma fatty acid profile 171 
There was no effect (P > 0.05) of dietary treatment on milk fat content of C4:0 to C18:0, 172 
C18:1 t-12, C18:1 n-9, C18:2 n-6, C20:0, C18:2 t-10, cis-12 CLA, C20:3 n-3 and C20:5 n-3, 173 
SFA, MUFA or total n-6 FA (Table 3). Milk fat content of C18:1 t 10, and c-9, t-11 CLA were 174 
similar at week 0 in cows fed either treatment, and increased (P < 0.05) in SCIM fed cows from 175 
week 2 onwards (Fig. 1a, b). There was also a higher milk fat content of C22:6n-3 in cows fed 176 
SCIM from week 2 onwards (P < 0.001), with the maximum difference between treatments of 177 
0.34 g/100g FA occurring at week 14 of the study (Fig. 1c). Milk fat content of total PUFA and 178 
total n-3 PUFA increased and the n-6 to n-3 PUFA ratio decreased in SCIM fed cows from week 179 
2 of the study (P < 0.05; Fig. 1d, e and f respectively), whilst C18:3 n-3 was lower at week 2 and 180 
C22:0 higher at weeks 8 and 14 in SCIM fed cows (Supplementary Fig. 1a and b). Milk fat 181 
content of C18:1 t-8, t-9, t-11and C20:3 n-6 were higher in cows fed SCIM than the Control. The 182 
content of C10:0, C12:0, C14:0, C14:1 n-5, C16:1 n-7, C18:1 t-8, C18:2 n-6, C20:0, and Ʃn-6 183 
FA increased with time, whilst C4:0, C6:0, C15:0, C17:0, C17:1, C18:1 t-12, C18:1 c-9,  C18:2 184 
t-10, c-12 CLA, C20:3 n-6, C20:5 n-3 and MUFA decreased over the study period.   185 
  There was no effect (P > 0.05) of dietary treatment on blood plasma fat content of 186 
C14:0 to C17:0, C18:1 t9, 12, or 15, C18:1 c-9, C20:5 n-3, total MUFA, PUFA or n-6 FA (Table 187 
4). There was an interaction between time (P < 0.001) on plasma C22:6 n-3 concentration, 188 
which was higher in SCIM fed cows from week two of the study, and remained high for the 189 
remainder of the study. In contrast, the ratio of the total n-6 to n-3 PUFA in blood plasma was 190 
lower (P < 0.001) from week 8 of the study in cows fed SCIM (Fig. 2b). Blood plasma C18:0, 191 
C20:4 n-6, C20:0 and the sum of the saturated FA were similar at week 0 and decreased in 192 
cows fed SCIM compared to the control (Supplementary Fig. 2 a,d,e,f), whilst C18 t-10, C18:3 193 
n-3, and the sum of the total PUFA increased in cows fed SCIM (Supplementary Fig 2 b,c,g).    194 
   195 
Plasma PGFM concentrations  196 
Plasma PGFM concentrations increased to a peak at 15-30 min following the oxytocin challenge 197 
(Fig. 3) before gradually returning to the basal level at 150 min for cows receiving either 198 
treatment. There was no effect of treatment on mean plasma PGFM concentration, area under 199 
the curve, or peak concentration (P > 0.05).  200 
 201 
Discussion 202 
Animal performance and blood metabolites 203 
The primary objective of this study was to determine the long-term effects of feeding microalgae 204 
that is high in C22:6 n-3 on milk and plasma fat concentration of LC n-3 PUFA and animal 205 
performance. The cows were fed 100 g of microalgae per d as higher inclusion levels have been 206 
shown to reduce DM intake and/or result in milk fat depression (Vanbergue et al. 2018; Marques 207 
et al., 2019), with the consequence of a reduced milk and/or fat yield. In the current study there 208 
was no effect of dietary treatment on DM intake, which averaged 22.1 kg/d over the 14 week 209 
period. This finding is in accordance with Till et al. (2019) who reported no effect on intake when 210 
cows were fed 100 g of SCIM/d. There is no clear consensus in the literature on the effects of 211 
the addition of marine lipids on milk performance, with the level and composition of the 212 
supplement, as well as the basal ration, having a major influence (Sinedino et al. 2017; Mattos 213 
et al. 2004). In the current study there was no effect of treatment on milk fat content or yield. 214 
Bauman & Griinari (2003) described how unique FA intermediates that are produced during the 215 
biohydrogenation of PUFA can cause an inhibitory effect on sterol regulatory element binding 216 
protein signaling on milk fat synthesis, with one intermediate identified as a potent inhibitor being 217 
C18:2t-10, c-12 CLA. In the current study milk fat concentration of C18:2 t-10, c-12 CLA was 218 
similar between treatments, and milk fat content was also unaffected by dietary treatment. Lock 219 
et al. (2007) investigated the effect of abomasal infusion of C18:1 t-10 on milk fat content in 220 
dairy cows and reported that it had no effect on milk fat synthesis. In the current study 221 
concentrations of C18: t-10 were higher in both blood plasma and milk of SCIM fed cows 222 
compared to the Control, yet milk fat content was unaffected, supporting that C18:1 t-10 is not 223 
a major factor controlling milk fat synthesis in dairy cows.  224 
In early lactation mobilisation of lipid reserves is required to compensate for the 225 
imbalance between energy consumed, and energy secreted in milk (Cozzi et al. 2011), and is 226 
generally associated with an elevation in plasma 3-OHB (McArt et al. 2013). In the current study 227 
blood samples were collected at one time point and differences may have been detected had 228 
samples been taken throughout the day, although previous studies have demonstrated no 229 
interaction between feeding microalgae and time of sampling on plasma metabolites (Till et al., 230 
2019). The mean plasma concentration of 3-OHB was not affected by dietary treatment and 231 
was within the accepted cut-point concentration of ≥ 1.2 mmol/l that is associated with sub-232 
clinical or clinical ketosis (McArt et al. 2013). The lack of a difference in milk energy output, 233 
along with a similar DMI and live weight change in cows receiving the Control or SCIM 234 
treatments may explain the similarity in the plasma metabolite concentrations between 235 
treatments. 236 
 237 
Milk and plasma fatty acid profile 238 
 Cows that received the SCIM supplement in the current study had higher milk and 239 
plasma concentrations of C22:6 n-3 compared to the Control from week 2 onwards, with the 240 
difference increasing until week 14 of the study. Most other studies that have fed microlage to 241 
dairy cows have used short-term, change over-studies or fed for a short period of time, and 242 
reported increases in C22:6 n-3 in milk of up to 0.46 g/100g FA with unprotected microalgae or 243 
0.76 g/100g FA with rumen protected microalgae (Till et al. 2019; Vanbergue et al. 2018). 244 
Studies that have fed microalgae for longer periods have reported an increase in the 245 
concentration of C22:6 n-3 in milk, but only measured milk FA at single time points and did not 246 
monitor the change over time (Sinedino et al. 2017). In contrast to the current findings, Shingfield 247 
et al. (2006) reported a temporal pattern in milk C22:6 n-3 concentration when FO was fed, 248 
reaching a maximum 5 days after FO introduction before declining. This response was 249 
suggested to be due to an adaptation of the rumen microbiome and progressive increase in the 250 
extent of biohydrogenation, or a shift in the incorporation of these FA from blood tracylglycerides 251 
toward phospholipids (Shingfield et al. 2006). In the current study milk samples were collected 252 
1 week after SCIM was introduced, and it is not possible to determine changes in milk fat 253 
C22:6n-3 concentration before this. However, the persistent increase in plasma and milk 254 
concentration over time does not support a significant ruminal adaptation or reduction in 255 
mammary uptake. 256 
 The inclusion of LC n-3 PUFA in the diet of ruminants typically lowers short and medium 257 
chained FA concentration in milk due to their inhibitory effects on mammary de novo FA 258 
synthesis (Shingfield et al. 2006), but in the current study the concentration of FA with a chain 259 
length < 16 was unchanged. A reduction in the milk fat concentration of C18:0 was observed by 260 
Till et al. (2019) when cows were fed SCIM, but in the current study there was only a trend  for 261 
a reduction in milk C18:0 in SCIM fed cows which may be attributed to the inhibitory effect of 262 
SCIM on the biohydrogenation of C18-unsaturated FA to C18:0 in the rumen. It was also 263 
suggested by Shingfield et al. (2006) that mammary synthesis of C18:1 cis-9 from C18:0 via Δ9-264 
desaturatase was required for the maintenance of the fluidity of milk fat (Bichi et al. 2013). This 265 
is difficult to conclude from the current study as milk concentrations of C18:1 cis-9 were similar 266 
between dietary treatments. 267 
   268 
Plasma PGFM concentration 269 
 The second objective of the current study was to investigate the effect of feeding SCIM 270 
on the plasma concentration of PGFM.  Diets high in n-3 FA may reduce PGF2α synthesis and 271 
consequently prevent the regression of the corpus luteum (CL), allowing continued secretion of 272 
progesterone that can help improve embryo survival (Gulliver et al. 2012). The effects of added 273 
PUFA on reproductive function have however, not always been consistent. To date only two 274 
other studies have reported the effects of feeding LC n-3 PUFA from microalge on reproduction 275 
in dairy cows, with Sinedino et al. (2017) reporting that microalgae fed cows had an increase in 276 
conception rate, and upregulation of the interferon-stimulated gene RTP4 which is associated 277 
with placental development, immunomodulation and conceptus elongation (Riberio et al., 2016). 278 
In contrast, Vlcek et al. (2017) reported no effect on the size of the pre-ovulatory follicle at first 279 
or second synchronised oestrus, although the size of the corpus luteum was larger in cows fed 280 
microalgae. However, neither  Sinedino et al. (2017) or Vlcek et al. (2017) determined the 281 
concentration of plasma PGF2α.  In the current study SCIM supplementation had no effect on 282 
mean, peak or area under the curve of plasma PGFM. In contrast, Dirandeh et al. (2013) 283 
investigated the effect of feeding linseed oil as a source of n-3 on plasma concentration of PGFM 284 
from calving to 70 days post calving and reported a reduced plasma PGFM concentration. 285 
Similarly, Mattos et al. (2004), fed FO to dairy cows from 21 days pre-partum until 21 days post-286 
partum, and reported a significant decrease in plasma PGFM concentrations at days 0, 0.5, 2 287 
and 2.5 post-partum in cows fed FO. By day 17 of the synchronized oestrus cycle, the cows 288 
selected for PGFM analysis in the current study had received the SCIM supplement for 39 ± 0.9 289 
days. Results from other studies suggest that this period of feeding was sufficient to affect the 290 
size of the corpus luteum and alter PGFM synthesis (Mattos et al. 2004; Petit et al. 2002). 291 
  292 
Conclusion 293 
The increase in milk and blood plasma C22:6 n-3 content over the 14 week study period 294 
suggest that the rumen microbial ecosystem did not adapt over time to the dietary 295 
supplementation of 100 g/d of SCIM. The increase in milk C22:6n-3 and cis-9, trans-11 CLA 296 
improves milk quality for human consumption without affecting milk performance. 297 
Supplementing dairy cows with SCIM at the rate and length of time in the current study did not 298 
affect plasma PGFM concentrations.  299 
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Table 1. Diet composition (kg/kg DM) of the pre-study and study diets that 
contained no SCIM (Control) or 100 g of microalgae per cow per day (SCIM) 
Ingredient Pre-study Basal diet 
  Maize silage 0.350 0.413    
  Grass silage - 0.130 
  Lucerne silage 0.152 - 
  Chopped wheat straw 0.019 - 
  Rapeseed meal 0.059 0.065 
  Wheat distillers dark grains 0.071 0.078 
  Soya bean meal 0.030 0.065 
  Palm kernel meal 0.020 0.022 
  Molasses 0.006 0.007 
  Caustic wheat 0.114 0.109 
  Distillery syrup1 0.040 - 
  Soya hulls 0.060 0.078 
  Food industry by product2 0.039 - 
  Rumen protected fat3 0.007 0.013 
  Rumen protected fat4 0.007 - 
  Minerals and vitamins 0.015 0.006 
    
Chemical composition  Control5 SCIM5 
  Organic matter 930 928 928 
  Crude protein 166 163 161 
  NDF 375 419 419 
  Fatty acid (g/kg DM)    
   C14:0 1.4 0.9 1.0 
   C16:0 15.8 10.0 12.6 
   C18:0 1.3 0.9 0.9 
   C18:1 n-9 8.6 7.9 8.3 
   C18:2 n-6 10.4 10.6 10.0 
   C18:3 n-3 1.7 1.7 1.3 
   C22:5 n-3 0.00 0.00 0.01 
   C22:6 n-3 0.00 0.00 0.7 
 
1Spey syrup; KW Feeds, Ternhill, UK. 2Sweetstarch: a by-product from the bakery, 
confectionary, pastry and breakfast cereal industries; KW Feeds, Ternhill, UK. 3Megalac, a 
calcium salt of palm fatty acids, Volac, Royston, UK). 4Butterfat Extra, a calcium salt of palm 
fatty acids fatty acids, Trident Feeds, Peterborough, UK.5The SCIM group received the basal 
ration with an additional 100 g/cow/day of microalgae, and the Control group received the 
basal ratio with an additional 100 g/cow/day of an equal mixture of a rolled wheat/sugarbeet 
feed mixture. 
 
 
 
 
 
 
 Table 2. Animal performance and blood metabolites in dairy cows fed no SCIM  
             (Control) or 100 g of microalgae per cow per day (SCIM) 
 
Treatment  
 
Control SCIM SED D T 
DM intake (kg/d) 22.1 22.0 0.70 0.905 <0.001 
Milk yield (kg/d) 39.6 39.9 0.78 0.980 <0.001 
Milk fat (g/kg) 37.5 36.9 1.59 0.702 0.048 
Fat yield (kg/d) 1.52 1.46 0.063 0.401 0.013 
Milk protein (g/kg) 31.3 31.5 0.55 0.670 <0.001 
Protein yield (g/kg) 1.27 1.25 0.034 0.584 <0.001 
Live weight (kg) 653 651 12.0 0.895 <0.001 
Live weight change, kg/d 0.29 0.17 0.084 0.179 -- 
Milk SCC (loge) 3.97 3.87 0.217 0.617 0.436 
Body condition 2.69 2.81 0.071 0.115 0.837 
Body condition change 0.04 -0.08 0.090 0.191 -- 
3-OHB (mmol/L) 1.07 1.12 0.087 0.550 0.457 
Glucose (mmol/L) 2.82 2.83 0.075 0.814 <0.001 
NEFA (mmol/L) 0.18 0.21 0.031 0.399 0.061 
                1Main effects of diet (D), time (T), and their interaction (D x T). There was no diet  
           x treatment interaction except for plasma glucose, which was approximately 0.1  
mmol/L higher in week 2 and 0.1 mmol/L lower in week 8 (P < 0.05) in cows fed the 
Control compared to SCIM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Milk fatty acid composition (g/100g of FA) of dairy cows fed no SCIM (Control) or 100 
g of microalgae per cow per day (SCIM) 
 
Treatment  P value1 
Fatty acid (g/100 g) Control SCIM SED D T D x T 
C4:0 2.37 2.37 0.083 0.969 <0.001 0.727 
C6:0 1.70 1.67 0.070 0.877 0.002 0.737 
C8:0 1.18 1.15 0.045 0.624 0.052 0.355 
C10:0 2.58 2.48 0.137 0.449 0.009 0.299 
C12:0 3.33 3.08 0.176 0.174 <0.001 0.540 
C14:0  10.4 9.90 0.309 0.164 <0.001 0.217 
C14:1 n-5 0.91 0.83 0.053 0.132 <0.001 0.430 
C15:0 1.04 0.98 0.040 0.146 0.002 0.345 
C16:0 31.0 30.6 0.616 0.507 0.124 0.250 
C16:1 n-7 0.51 0.52 0.020 0.816 0.013 0.361 
C17:0 0.51 0.52 0.017 0.845 <0.001 0.228 
C17:1 0.26 0.26 0.020 0.924 <0.001 0.488 
C18:0 8.38 7.90 0.233 0.058 0.131 0.215 
C18:1 t-8 0.26 0.44 0.034 0.002 <0.001 0.130 
C18:1 t-9 0.24 0.34 0.019 <.001 0.506 0.176 
C18:1 t-10 0.55 0.94 0.166 0.034 0.026 0.033 
C18:1 t-11 0.84 1.22 0.101 0.002 0.109 0.356 
C18:1 t-12 0.48 0.56 0.046 0.088 0.009 0.152 
C18:1 n-9 21.1 20.4 0.87 0.456 <0.001 0.069 
C18:2 n-6 2.93 2.99 0.102 0.620 0.009 0.205 
C20:0 0.13 0.13 0.009 0.876 0.023 0.680 
C18:3 n-3 0.48 0.47 0.023 0.789 0.109 0.012 
C18:2 c-9, t-11 CLA 0.57 0.75 0.054 <.001 0.002 0.049 
C18:2 t-10, c-12 CLA 0.05 0.04 0.005 0.958 <0.001 0.947 
C22:0 0.12 0.08 0.011 0.002 0.260 <0.001 
C20:3 n-6 0.05 0.07 0.006 0.034 0.008 0.062 
C20:3 n-3 0.18 0.17 0.012 0.648 0.129 0.216 
C20:5 n-3 0.08 0.09 0.009 0.376 <0.001 0.242 
C22:6 n-3 0.04 0.22 0.015 <.001 <0.001 <.001 
Indices       
     ƩSFA 62.9 60.7 1.06 0.059 0.150 0.423 
     ƩMUFA 26.1 26.7 0.97 0.570 <0.001 0.272 
     ƩPUFA 4.37 4.80 0.151 0.012 <0.001 0.002 
     Ʃn-3 0.83 0.97 0.039 0.002 0.121 0.023 
     Ʃn-6 2.96 3.03 0.100 0.505 <0.001 0.092 
     n-6:n-3 3.75 3.24 0.184 0.003 0.817 0.032 
1Main effects of diet (D), time (T), and their interaction (D x T) 
 
 
 
Table 4. Total plasma lipid fatty acid composition (g/100g of FA) of dairy cows fed no SCIM 
(Control) or 100 g of microalgae/cow per day (SCIM) 
 
Treatment  P value1 
Fatty acid (g/100 g) Control SCIM SED D T D x T 
C14:0 0.82 0.66 0.103 0.141 <0.001 0.084 
C14:1 n-5 0.18 0.13 0.021 0.112 <0.008 0.482 
C15:0 0.40 0.42 0.015 0.241 <0.001 0.436 
C16:0 12.1 12.4 0.36 0.363 <0.001 0.845 
C16:1 n-7 0.78 0.77 0.074 0.854 <0.001 0.859 
C17:0 0.63 0.62 0.027 0.682 <0.001 0.497 
C18:0 15.3 14.3 0.33 0.016 0.532 0.027 
C18:1 t 6-8 0.10 0.14 0.012 0.014 0.003 0.291 
C18:1 t-9 0.13 0.16 0.022 0.151 0.038 0.388 
C18:1 t-10 0.17 0.31 0.057 0.029 0.189 0.012 
C18:1 t-11 0.44 0.64 0.045 <0.001 <0.001 0.056 
C18:1 t-12 0.37 0.39 0.020 0.317 <0.001 0.349 
C18:1 t-15 0.13 0.13 0.008 0.902 0.004 0.489 
C18:1 c-9 8.45 7.67 0.387 0.070 <0.001 0.577 
C18:2 n-6 44.2 45.6 0.70 0.067 <0.001 0.259 
C20:0 0.64 0.41 0.039 <0.001 <0.001 <0.001 
C18:3 n-3 3.34 3.60 0.157 0.120 <0.001 0.035 
ΣCLA 0.10 0.12 0.009 0.053 <0.001 0.333 
C20:4 n-6 1.75 1.56 0.073 0.022 <0.001 <0.001 
C20:5 n-3 0.47 0.50 0.040 0.388 <0.001 0.065 
C22:5 n-6 0.29 0.17 0.042 0.014 0.033 0.093 
C22:5 n-3 0.71 0.53 0.041 0.001 <0.001 0.065 
C22:6 n-3 0.13 1.11 0.028 <0.001 <0.001 <0.001 
Indices       
     ƩSFA 31.0 29.7 0.48 0.017 <0.001 0.014 
     ƩMUFA 12.7 12.3 0.45 0.318 <0.001 0.722 
     ƩPUFA 52.6 54.3 0.85 0.077 <0.001 0.076 
     Ʃn-3 4.65 5.74 0.283 0.005 <0.001 <0.001 
     Ʃn-6 47.8 48.5 0.66 0.331 <0.001 0.492 
     n-6:n-3 10.35 8.61 0.821 0.132 <0.001 <0.001 
1Main effects of diet (D), time (T), and their interaction (D x T) 
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Fig. 1. Milk fat concentration of (a) C18:1 trans-10 (b) C18:2 cis-9 trans-11 CLA (c) C22:6 n-3, 
(d) sum of PUFA (e) sum of n-3 PUFA and (f) n-6 tp n-3 ratio in dairy cows fed no SCIM 
(Control ●) or 100 g per cow per day of microalgae (SCIM ▲). SED = 0.25, 0.071, 0.030, 0.22 
0.070 g/100g and 0.28 respectively. Within time points, treatments differ at P < 0.05, P<0.01 
or P < 0.001 are denoted by * , ** or *** respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(e) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Blood plasma fat concentration of (a) C22:6 n-3 (b) n-6 to n-3 PUFA ratio in dairy cows 
fed no SCIM (Control ●) or 100 g per cow per day of microalgae (SCIM ▲). SED = 0.045 
g/100g and 1.07 respectively. Within time points, treatments differ at P < 0.05, P<0.01 or P < 
0.001 are denoted by * , ** or *** respectively. 
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 Fig. 3. Plasma 13,14-dihydro-15-keto PGF2α metabolite (PGFM) concentration after an 
oxytocin challenge (time = 0) in cows fed no SCIM (Control ●) or 100 g per cow per day of 
microalgae (SCIM ▲). Arrow represents when oxytocin was administered. SED = 11.3 pg/ml. 
Significance for Diet, Time and D x T = 0.307, 0.003 and 0.351 respectively. For the Control 
and SCIM, peak value = 67.5 and 73.9 pg/ml (SED 17.61; P = 0.731) and area under curve = 
2236 and 4046 (SED = 987.0; P = 0.126) respectively. 
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